1
|
Gasoyan H, Pfoh ER, Schulte R, Sullivan E, Le P, Rothberg MB. Association of patient characteristics and insurance type with anti-obesity medications prescribing and fills. Diabetes Obes Metab 2024; 26:1687-1696. [PMID: 38287140 PMCID: PMC11001528 DOI: 10.1111/dom.15473] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [MESH Headings] [Grants] [Track Full Text] [Journal Information] [Submit a Manuscript] [Subscribe] [Scholar Register] [Received: 10/17/2023] [Revised: 01/02/2024] [Accepted: 01/12/2024] [Indexed: 01/31/2024]
Abstract
AIM To characterize factors associated with the receipt of anti-obesity medication (AOM) prescription and fill. MATERIALS AND METHODS This retrospective cohort study used electronic health records from 1 January 2015 to 30 June 2023, in a large health system in Ohio and Florida. Adults with a body mass index ≥30 kg/m2 who attended ≥1 weight-management programme or had an initial AOM prescription between 1 July 2015 and 31 December 2022, were included. The main measures were a prescription for an AOM (naltrexone-bupropion, orlistat, phentermine-topiramate, liraglutide 3.0 mg and semaglutide 2.4 mg) and an AOM fill during the study follow-up. RESULTS We identified 50 678 adults, with a mean body mass index of 38 ± 8 kg/m2 and follow-up of 4.7 ± 2.4 years. Only 8.0% of the cohort had AOM prescriptions and 4.4% had filled prescriptions. In the multivariable analyses, being a man, Black, Hispanic and other race/ethnicity (vs. White), Medicaid, traditional Medicare, Medicare Advantage, self-pay and other insurance types (vs. private insurance) and fourth quartile of the area deprivation index (vs. first quartile) were associated with lower odds of a new prescription. Hispanic ethnicity, being a man, Medicaid, traditional Medicare and Medicare Advantage insurance types, liraglutide and orlistat (vs. naltrexone-buproprion) were associated with lower odds of AOM fill, while phentermine-topiramate was associated with higher odds. Among privately insured individuals, the insurance carrier was associated with both the odds of AOM prescription and fill. CONCLUSIONS Significant disparities exist in access to AOM both at the prescribing stage and getting the prescription filled based on patient characteristics and insurance type.
Collapse
Affiliation(s)
- Hamlet Gasoyan
- Center for Value-Based Care Research, Department of Internal Medicine and Geriatrics, Primary Care Institute, Cleveland Clinic, Cleveland, OH
- Cleveland Clinic Lerner College of Medicine of Case Western Reserve University, Cleveland, OH
| | - Elizabeth R. Pfoh
- Center for Value-Based Care Research, Department of Internal Medicine and Geriatrics, Primary Care Institute, Cleveland Clinic, Cleveland, OH
- Cleveland Clinic Lerner College of Medicine of Case Western Reserve University, Cleveland, OH
| | - Rebecca Schulte
- Department of Quantitative Health Sciences, Lerner Research Institute, Cleveland Clinic, Cleveland, OH
| | - Erin Sullivan
- Cleveland Clinic Lerner College of Medicine of Case Western Reserve University, Cleveland, OH
| | - Phuc Le
- Center for Value-Based Care Research, Department of Internal Medicine and Geriatrics, Primary Care Institute, Cleveland Clinic, Cleveland, OH
- Cleveland Clinic Lerner College of Medicine of Case Western Reserve University, Cleveland, OH
| | - Michael B. Rothberg
- Center for Value-Based Care Research, Department of Internal Medicine and Geriatrics, Primary Care Institute, Cleveland Clinic, Cleveland, OH
- Cleveland Clinic Lerner College of Medicine of Case Western Reserve University, Cleveland, OH
| |
Collapse
|
2
|
Avery J, Leak-Johnson T, Francis SC. Association between MCU Gene Polymorphisms with Obesity: Findings from the All of Us Research Program. Genes (Basel) 2024; 15:512. [PMID: 38674446 PMCID: PMC11050077 DOI: 10.3390/genes15040512] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [MESH Headings] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 03/19/2024] [Revised: 04/09/2024] [Accepted: 04/13/2024] [Indexed: 04/28/2024] Open
Abstract
Obesity is a public health crisis, and its prevalence disproportionately affects African Americans in the United States. Dysregulation of organelle calcium homeostasis is associated with obesity. The mitochondrial calcium uniporter (MCU) complex is primarily responsible for mitochondrial calcium homeostasis. Obesity is a multifactorial disease in which genetic underpinnings such as single-nucleotide polymorphisms (SNPs) may contribute to disease progression. The objective of this study was to identify genetic variations of MCU with anthropometric measurements and obesity in the All of Us Research Program. METHODS We used an additive genetic model to assess the association between obesity traits (body mass index (BMI), waist and hip circumference) and selected MCU SNPs in 19,325 participants (3221 normal weight and 16,104 obese). Eleven common MCU SNPs with a minor allele frequency ≥ 5% were used for analysis. RESULTS We observed three MCU SNPs in self-reported Black/African American (B/AA) men, and six MCU SNPs in B/AA women associated with increased risk of obesity, whereas six MCU SNPs in White men, and nine MCU SNPs in White women were protective against obesity development. CONCLUSIONS This study found associations of MCU SNPs with obesity, providing evidence of a potential predictor of obesity susceptibility in B/AA adults.
Collapse
Affiliation(s)
- Jade Avery
- Department of Physiology, Morehouse School of Medicine, Atlanta, GA 30310, USA;
| | - Tennille Leak-Johnson
- Department of Physiology, Morehouse School of Medicine, Atlanta, GA 30310, USA;
- Institute of Translational Genomic Medicine, Morehouse School of Medicine, Atlanta, GA 30310, USA
| | - Sharon C. Francis
- Department of Physiology, Morehouse School of Medicine, Atlanta, GA 30310, USA;
- Cardiovascular Research Institute, Morehouse School of Medicine, Atlanta, GA 30310, USA
| |
Collapse
|
3
|
Madu CT, Lee TF, Sohn A, Hu J, Matayev R, Paranjpe V, Fam J, Wronka A, Kim ET, Zambrano R, Wollstein G, Schuman JS. Disparities in Visual Field Testing Frequency Among Subjects With Glaucoma. Transl Vis Sci Technol 2024; 13:2. [PMID: 38564202 PMCID: PMC10996970 DOI: 10.1167/tvst.13.4.2] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [MESH Headings] [Grants] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 06/30/2023] [Accepted: 01/23/2024] [Indexed: 04/04/2024] Open
Abstract
Purpose Prior evidence suggests racial disparities in the utilization of visual field testing (VFT) for the diagnosis and monitoring of glaucoma. In this study, we considered the effect of baseline glaucoma severity and socioeconomic disadvantage along with other potential confounders such as test reliability, ancillary tests, and glaucoma surgeries on racial disparity in the frequency of VFT. Methods The records of all subjects with a diagnosis of glaucoma who received VFT at an academic, tertiary care facility from January 2018 to December 2021 were accessed. Analysis was performed to compare VFT frequency, the total number of office visits (DoS), and the ratio of VFT frequency to DoS (VFT/DoS) across self-reported races while controlling for sex, age, socioeconomic disadvantage (Area Deprivation Index), VF reliability indicators and baseline mean deviation, optical coherence tomography frequency, and glaucoma surgeries. Results Among the 2654 subjects (1515 White, 782 Black, and 357 Asian) included in this study, Black subjects had the worst socioeconomic status and disease severity at baseline. They also experienced a 3% lower VFT/DoS ratio compared to White subjects (P = 0.031). Asian subjects had a 5% lower VFT/DoS ratio compared to White subjects (P = 0.015). Discussion We identified racial disparity in performing VFT in subjects with glaucoma even when multiple confounders were considered. Further investigation is necessary to identify other race-associated factors to work toward reducing racial disparities in VFT. Translational Relevance Black and Asian subjects with glaucoma receive fewer VFT per visit compared to White subjects even when considering socioeconomic disadvantage and disease severity.
Collapse
Affiliation(s)
- Chisom T. Madu
- Department of Ophthalmology, NYU Grossman School of Medicine, New York University, New York, NY, USA
| | - Ting-Fang Lee
- Department of Ophthalmology, NYU Grossman School of Medicine, New York University, New York, NY, USA
- Department of Population Health, NYU Grossman School of Medicine, New York University, New York, NY, USA
| | - Ashley Sohn
- Department of Ophthalmology, NYU Grossman School of Medicine, New York University, New York, NY, USA
| | - Jiyuan Hu
- Department of Population Health, NYU Grossman School of Medicine, New York University, New York, NY, USA
| | - Rachel Matayev
- Department of Ophthalmology, NYU Grossman School of Medicine, New York University, New York, NY, USA
| | - Vikram Paranjpe
- Department of Ophthalmology, NYU Grossman School of Medicine, New York University, New York, NY, USA
| | - Jonathan Fam
- Department of Ophthalmology, NYU Grossman School of Medicine, New York University, New York, NY, USA
| | - Andrew Wronka
- Department of Ophthalmology, NYU Grossman School of Medicine, New York University, New York, NY, USA
| | - Eleanore T. Kim
- Department of Ophthalmology, NYU Grossman School of Medicine, New York University, New York, NY, USA
| | | | - Gadi Wollstein
- Glaucoma Service, Wills Eye Hospital, Philadelphia, PA, USA
| | | |
Collapse
|
4
|
Godziuk K, Hawker GA. Obesity and body mass index: Past and future considerations in osteoarthritis research. Osteoarthritis Cartilage 2024; 32:452-459. [PMID: 38354848 DOI: 10.1016/j.joca.2024.02.003] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [MESH Headings] [Track Full Text] [Journal Information] [Submit a Manuscript] [Subscribe] [Scholar Register] [Received: 09/01/2023] [Revised: 01/12/2024] [Accepted: 02/06/2024] [Indexed: 02/16/2024]
Abstract
Obesity is an important topic for the osteoarthritis (OA) scientific community. However, the predominant use of body mass index (BMI) to define obesity in OA research is associated with uncertainties and limitations. These include an inability to discern fat and muscle mass, account for sex-differences in fat distribution, or identify adiposity-related health impairments. A focus on BMI in OA research may influence weight bias in clinical practice and impact disparities in access to effective OA treatments. To ensure that our understanding and approaches to improve health outcomes for individuals with or at risk for OA continues to advance in the next decade, future research will need to consider alternative measures beyond BMI for obesity identification and align with evolving obesity science. OA researchers must be aware of issues associated with weight stigma and work to minimize negative generalizations based on BMI.
Collapse
Affiliation(s)
- Kristine Godziuk
- Department of Agricultural, Food, and Nutritional Science, University of Alberta, Edmonton, AB, Canada.
| | - Gillian A Hawker
- Department of Medicine, University of Toronto, Toronto, ON, Canada
| |
Collapse
|
5
|
Tu L, Marzouk S, Dowdell KN, Stanford FC. Reimagining Urban Spaces: Green Spaces, Obesity, and Health Resilience in an Era of Extreme Heat. J Urban Health 2024; 101:344-348. [PMID: 38441853 PMCID: PMC11052730 DOI: 10.1007/s11524-024-00834-2] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [MESH Headings] [Grants] [Track Full Text] [Journal Information] [Submit a Manuscript] [Subscribe] [Scholar Register] [Accepted: 01/24/2024] [Indexed: 04/02/2024]
Abstract
Record-breaking heat waves intensified by climate change pose both environmental and health threats, necessitating a balance between urban sustainability and well-being. Extreme heat and limited green space access are drivers of obesity prevalence, with decreased proximity to green spaces correlating with higher rates of obesity in nearby communities. In contrast, access to such green spaces fosters physical activity, well-being, and community cohesion, especially crucial in marginalized communities facing health disparities due to historical policies like redlining and underinvestment in social gathering spaces. Despite challenges, green space investment offers healthcare savings and environmental gains, necessitating a shift in perception towards viewing green spaces as essential for urban living. As heat waves persist, integrating health and sustainability in urban planning is paramount. Health and medical communities must play an active role in advocating for equitable access to urban green spaces, as they possess influential positions to address climate-related health disparities through localized advocacy.
Collapse
Affiliation(s)
- Lucy Tu
- Department of Sociology, Harvard College, Cambridge, MA, USA
- Department of the History of Science, Harvard College, Cambridge, MA, USA
| | - Sammer Marzouk
- Department of Medicine, Northwestern Feinberg School of Medicine, Chicago, IL, USA
| | - Kimberly N Dowdell
- HOK Architects, American Institute of Architects (AIA), Chicago, IL, USA
| | - Fatima Cody Stanford
- Division of Endocrinology-Neuroendocrine, Department of Medicine, MGH Weight Center, Massachusetts General Hospital, Boston, MA, USA.
- Division of Endocrinology, Department of Pediatrics, Nutrition Obesity Research Center at Harvard (NORCH), Massachusetts General Hospital, Boston, MA, USA.
| |
Collapse
|
6
|
Khoo B, Tan TMM. GLP-1 analogue therapy for obesity in people from Asia. Lancet Diabetes Endocrinol 2024; 12:153-154. [PMID: 38330985 DOI: 10.1016/s2213-8587(24)00031-7] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [MESH Headings] [Track Full Text] [Journal Information] [Submit a Manuscript] [Subscribe] [Scholar Register] [Received: 01/20/2024] [Accepted: 01/22/2024] [Indexed: 02/10/2024]
Affiliation(s)
- Bernard Khoo
- Endocrinology, Division of Medicine, University College London, Royal Free Campus, London NW3 2PF, UK
| | - Tricia M-M Tan
- Department of Metabolism, Digestion and Reproduction, Imperial College London, London W12 0HS, UK.
| |
Collapse
|
7
|
Abstract
2023 was the most memorable year on record for obesity. The American Academy of Pediatrics recognized the complex, multifactorial nature of obesity and the broad range of treatments necessary to care for pediatric patients. The first-ever triple agonist and high-potency oral GLP1 agonist was introduced with unprecedented results.
Collapse
Affiliation(s)
- Fatima Cody Stanford
- Massachusetts General Hospital, MGH Weight Center, Department of Medicine-Division of Endocrinology-Neuroendocrine, Department of Pediatrics-Division of Endocrinology, Nutrition Obesity Research Center at Harvard (NORCH), Boston, MA, USA.
| |
Collapse
|
8
|
Waldrop SW, Johnson VR, Stanford FC. Inequalities in the provision of GLP-1 receptor agonists for the treatment of obesity. Nat Med 2024; 30:22-25. [PMID: 38172631 PMCID: PMC10921848 DOI: 10.1038/s41591-023-02669-x] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [MESH Headings] [Grants] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 01/05/2024]
Abstract
GLP-1 receptor agonists are effective treatments for obesity but are less accessible worldwide than pharmacological treatments for diabetes, reflecting biases and lack of education, and perpetuating health inequalities.
Collapse
Affiliation(s)
- Stephanie W Waldrop
- University of Colorado School of Medicine-Anschutz Medical Campus, Department of Pediatrics, Section on Nutrition and Lifestyle Medicine, Nutrition Obesity Research Center at the University of Colorado (CUNORC), Aurora, CO, USA.
| | - Veronica R Johnson
- Northwestern University Feinberg School of Medicine, Department of Medicine, Division of General Internal Medicine, Chicago, IL, USA
| | - Fatima Cody Stanford
- Massachusetts General Hospital, Massachusetts General Hospital Weight Center, Department of Medicine-Division of Endocrinology-Neuroendocrine, Department of Pediatrics-Division of Endocrinology, Nutrition Obesity Research Center at Harvard (NORCH), Boston, MA, USA
| |
Collapse
|
9
|
Pinkney JA, Davis JB, Collins JE, Shebl FM, Jamison MP, Acosta Julbe JI, Bogart LM, Ojikutu BO, Chen AF, Nelson SB. Racial Disparities in Periprosthetic Joint Infections after Primary Total Joint Arthroplasty: A Retrospective Study. Antibiotics (Basel) 2023; 12:1629. [PMID: 37998831 PMCID: PMC10668943 DOI: 10.3390/antibiotics12111629] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [Grants] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 09/28/2023] [Revised: 11/05/2023] [Accepted: 11/12/2023] [Indexed: 11/25/2023] Open
Abstract
In the United States, racial disparities have been observed in complications following total joint arthroplasty (TJA), including readmissions and mortality. It is unclear whether such disparities also exist for periprosthetic joint infection (PJI). The clinical data registry of a large New England hospital system was used to identify patients who underwent TJA between January 2018 and December 2021. The comorbidities were evaluated using the Elixhauser Comorbidity Index (ECI). We used Poisson regression to assess the relationship between PJI and race by estimating cumulative incidence ratios (cIRs) and 95% confidence intervals (CIs). We adjusted for age and sex and examined whether ECI was a mediator using structural equation modeling. The final analytic dataset included 10,018 TJAs in 9681 individuals [mean age (SD) 69 (10)]. The majority (96.5%) of the TJAs were performed in non-Hispanic (NH) White individuals. The incidence of PJI was higher among NH Black individuals (3.1%) compared with NH White individuals (1.6%) [adjusted cIR = 2.12, 95%CI = 1.16-3.89; p = 0.015]. Comorbidities significantly mediated the association between race and PJI, accounting for 26% of the total effect of race on PJI incidence. Interventions that increase access to high-quality treatments for comorbidities before and after TJA may reduce racial disparities in PJI.
Collapse
Affiliation(s)
- Jodian A. Pinkney
- Massachusetts General Hospital, Boston, MA 02114, USA; (F.M.S.)
- Harvard Medical School, Boston, MA 02115, USA; (J.E.C.)
| | - Joshua B. Davis
- Brigham and Women’s Hospital, Boston, MA 02115, USA; (J.B.D.); (M.P.J.); (J.I.A.J.)
| | - Jamie E. Collins
- Harvard Medical School, Boston, MA 02115, USA; (J.E.C.)
- Brigham and Women’s Hospital, Boston, MA 02115, USA; (J.B.D.); (M.P.J.); (J.I.A.J.)
| | - Fatma M. Shebl
- Massachusetts General Hospital, Boston, MA 02114, USA; (F.M.S.)
| | - Matthew P. Jamison
- Brigham and Women’s Hospital, Boston, MA 02115, USA; (J.B.D.); (M.P.J.); (J.I.A.J.)
| | - Jose I. Acosta Julbe
- Brigham and Women’s Hospital, Boston, MA 02115, USA; (J.B.D.); (M.P.J.); (J.I.A.J.)
| | - Laura M. Bogart
- RAND Corporation, Santa Monica, CA 90401, USA
- Charles R. Drew University of Medicine and Science, Los Angeles, CA 90059, USA
| | - Bisola O. Ojikutu
- Massachusetts General Hospital, Boston, MA 02114, USA; (F.M.S.)
- Harvard Medical School, Boston, MA 02115, USA; (J.E.C.)
- Brigham and Women’s Hospital, Boston, MA 02115, USA; (J.B.D.); (M.P.J.); (J.I.A.J.)
- Boston Public Health Commission, Boston, MA 02118, USA
| | - Antonia F. Chen
- Harvard Medical School, Boston, MA 02115, USA; (J.E.C.)
- Brigham and Women’s Hospital, Boston, MA 02115, USA; (J.B.D.); (M.P.J.); (J.I.A.J.)
| | - Sandra B. Nelson
- Massachusetts General Hospital, Boston, MA 02114, USA; (F.M.S.)
- Harvard Medical School, Boston, MA 02115, USA; (J.E.C.)
| |
Collapse
|